Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple mutated AML

ABSTRACT: HLF was knocked down in a primary human triple mutated AML sample using shRNA against human HLF versus shRNA against luciferase (shLuc) as control to determine gene expression changes 72 hours after lentiviral transduction.

ORGANISM(S): Homo sapiens

PROVIDER: GSE128848 | GEO | 2022/03/26

REPOSITORIES: GEO